259 Phase II trial of recombinant interleukin-4 (IL-4 SCH 39400) in advanced non-small cell lung cancer (NSCLC); a dose ranging study
1997
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI